Cardiovascular Drugs and Therapy

Cardiovascular Drugs and Therapy Journal

Publication venue for

Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients 2025
Cardiovascular Outcomes and Angiotensin Converting Enzyme Inhibitors: Beyond Blood Pressure Control. 23:109-111. 2009

International Standard Serial Number (ISSN)

0920-3206